Sionna Therapeutics, Inc. Common Stock (SION) — Long-term Investment Intensity
Sionna Therapeutics, Inc. Common Stock (SION) has a Long-term Investment Intensity of 22.8% as of December 2025. Long-term investments of $74.42 Million represent 22.8% of total assets of $325.95 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore SION cash flow metrics to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sionna Therapeutics, Inc. Common Stock Long-term Investment Intensity (2024–2025)
This chart shows how Sionna Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the intensity stands at 22.8%, reflecting long-term investments of $74.42 Million against total assets of $325.95 Million USD. Explore Sionna Therapeutics, Inc. Common Stock debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Sionna Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Long-term Investment Intensity for Sionna Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Sionna Therapeutics, Inc. Common Stock (SION) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 22.8% | $74.42 Million | $325.95 Million | ▲ +11.8 pp |
| 2024 | 11.0% | $20.50 Million | $185.75 Million | — |